CEO Message

Frinsulin Biotech is a biotech venture company that
pursues innovative drug development based on a completely
new mechanism of action against insulin resistance.

We aim to be a leading company in developing new drugs that
liberate from metabolic diseases originating from insulin resistance.

CEO Park Young Jun